American Cancer Society: Cancer Facts and Figures 2009. [http://www.cancer.org/downloads/STT/500809web.pdf]
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer Statistics, 2009. CA Cancer J Clin. 2009, 59: 225-249. 10.3322/caac.20006.
Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ: SEER Cancer Statistics Review. 1975, National Cancer Institute. Bethesda, MD, based on November 2007 SEER data submission, posted to the SEER web site 2008, [http://seer.cancer.gov/csr/1975_2005/]
Stanford JL, Stephenson RA, Coyle LM, Cerhan J, Correa R, Eley JW: Prostate Cancer Trends 1973-1995. 1999, SEER Program, National Cancer Institute. NIH publication, 99-4543.
Andriole GL, Crawford ED, Grubb RLI, Buys SS, Chia D, Church TR: Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009, 360: 1310-1319. 10.1056/NEJMoa0810696.
Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V: Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009, 360: 1320-1328. 10.1056/NEJMoa0810084.
Collins MM, Barry MJ: Controversies in prostate cancer screening. Analogies to the early lung cancer screening debate. JAMA. 1996, 276: 1976-1979. 10.1001/jama.276.24.1976.
Laara E, Day NE, Hakama M: Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet. 1987, 1: 1247-1249.
Woolf SH, Lawrence RS: Preserving scientific debate and patient choice: lessons from the Consensus Panel on Mammography Screening. National Institutes of Health. JAMA. 1997, 278: 2105-2108. 10.1001/jama.278.23.2105.
Brawley OW, Kramer BS: Cancer screening in theory and in practice. J Clin Oncol. 2005, 23: 293-300. 10.1200/JCO.2005.06.107.
Curry SJ, Byers T, Hewitt MA, National Cancer Policy Board, Institute of Medicine, National Research Council: Fulfilling the Potential of Cancer Prevention and Early Detection. 2003, Washington, DC: National Academies Press
Mahadevia PJ, Fleisher LA, Frick KD, Eng J, Goodman SN, Powe NR: Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis. JAMA. 2003, 289: 313-322. 10.1001/jama.289.3.313.
Ornstein DK, Rayford W, Fusaro VA, Conrads TP, Ross SJ, Hitt BA: Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml. J Urol. 2004, 172: 1302-1305. 10.1097/01.ju.0000139572.88463.39.
Watson RW, Schalken JA: Future opportunities for the diagnosis and treatment of prostate cancer. Prostate Cancer Prostatic Dis. 2004, 7 (Suppl 1): S8-S13. 10.1038/sj.pcan.4500742.
American Academy of Family Physicians: Summary of Recommendations for Clinical Preventive Services. Revision: 6.8. 2009, [http://www.aafp.org/online/etc/medialib/aafp_org/documents/clinical/CPS/rcps08-2005.Par.0001.File.tmp/CPSapprovedApril2009.pdf]
American Cancer Society: Overview: Prostate Cancer. 2009, Atlanta, GA: American Cancer Society, [http://www.cancer.org/docroot/CRI/content/CRI_2_2_3X_How_is_prostate_cancer_found_36.asp?sitearea]
American College of Physicians: Clinical Guideline: Part III: Screening for Prostate Cancer. Ann Intern Med. 1997, 126: 480-484.
American Medical Association: Annual meeting of the American Medical Association: Reports of the Council on Scientific Affairs. Chicago, IL. 2000, [http://www.ama-assn.org/ama1/pub/upload/mm/443/csaa-00.pdf]
American Urological Association Education and Research Inc: Prostate-Specific Antigen Best Practice Statement. American Urological Association: 2009 Update. 2009, [http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines/main-reports/psa09.pdf]
Lim LS, Sherin K: Screening for prostate cancer in U.S. men ACPM position statement on preventive practice. Am J Prev Med. 2008, 34: 164-170. 10.1016/j.amepre.2007.10.003.
U.S.Preventive Services Task Force (USPSTF): Screening for Prostate Cancer: Recommendations and Rationale. AHRQ publication 08-05121-EF-2. 2008, Agency for Healthcare Research and Quality, Rockville, MD, [http://www.ahrq.gov/clinic/uspstf08/prostate/prostaters.htm]
Chapman GB, Sonnenberg FA: Introduction. Decision Making in Health Care: Theory, Psychology, and Applications. Edited by: Chapman GB, Sonnenberg FA. 2000, New York: Cambridge University Press, 3-19.
Rimer BK, Briss PA, Zeller PK, Chan EC, Woolf SH: Informed decision making: what is its role in cancer screening?. Cancer. 2004, 101: 1214-1228. 10.1002/cncr.20512.
O'Connor AM, Elwyn G, Barratt A, Barry M, Coulter A, Holmes-Rovner M: International Patient Decision Aid Standards (IPDAS) Collaboration. Criteria for Judging the Quality of Patient Decision Aids. 2005, [http://ipdas.ohri.ca/IPDAS_checklist.pdf]
O'Brien MA, Whelan TJ, Villasis-Keever M, Gafni A, Charles C, Roberts R: Are cancer-related decision aids effective? A systematic review and meta-analysis. J Clin Oncol. 2009, 27: 974-985. 10.1200/JCO.2007.16.0101.
Frosch DL, Kaplan RM, Felitti VJ: A randomized controlled trial comparing internet and video to facilitate patient education for men considering the prostate specific antigen test. J Gen Intern Med. 2003, 18: 781-787. 10.1046/j.1525-1497.2003.20911.x.
Frosch DL, Bhatnagar V, Tally S, Hamori CJ, Kaplan RM: Internet patient decision support: a randomized controlled trial comparing alternative approaches for men considering prostate cancer screening. Arch Intern Med. 2008, 168: 363-369. 10.1001/archinternmed.2007.111.
Ilic D, Egberts K, McKenzie JE, Risbridger G, Green S: Informing men about prostate cancer screening: a randomized controlled trial of patient education materials. J Gen Intern Med. 2008, 23: 466-471. 10.1007/s11606-007-0466-z.
Krist AH, Woolf SH, Johnson RE, Kerns JW: Patient education on prostate cancer screening and involvement in decision making. Ann Fam Med. 2007, 5: 112-119. 10.1370/afm.623.
Ruffin MT, Fetters MD, Jimbo M: Preference-based electronic decision aid to promote colorectal cancer screening: results of a randomized controlled trial. Prev Med. 2007, 45: 267-273. 10.1016/j.ypmed.2007.07.003.
Thomson MD, Hoffman-Goetz L: Readability and cultural sensitivity of web-based patient decision aids for cancer screening and treatment: a systematic review. Med Inform Internet Med. 2007, 32: 263-286. 10.1080/14639230701780408.
Pew Internet and American Life Project: Derived From Trends--Usage Over Time. [http://www.pewinternet.org/Static-Pages/Trend-Data/Usage-Over-Time.aspx]
Fox S, Pew Internet American Life Project: Digital Divisions: There are clear differences among those with broadband connections, dial-up connections, and no connections at all to the internet. [http://www.pewinternet.org/~/media//Files/Reports/2005/PIP_Digital_Divisions_Oct_5_2005.pdf.pdf]
U.S.Department of Commerce, Economics and Statistics Administration, National Telecommunications and Information Administration: A Nation Online: how Americans are expanding their use of the Internet. [http://www.ntia.doc.gov/ntiahome/dn/anationonline2.pdf]
Volk RJ, Hawley ST, Kneuper S, Holden EW, Stroud LA, Cooper CP: Trials of decision aids for prostate cancer screening: a systematic review. Am J Prev Med. 2007, 33: 428-434. 10.1016/j.amepre.2007.07.030.
Kripalani S, Sharma J, Justice E, Justice J, Spiker C, Laufman LE: Low-literacy interventions to promote discussion of prostate cancer: a randomized controlled trial. Am J Prev Med. 2007, 33: 83-90. 10.1016/j.amepre.2007.03.018.
Stamatiou K, Skolarikos A, Heretis I, Papadimitriou V, Alevizos A, Ilias G: Does educational printed material manage to change compliance with prostate cancer screening?. World J Urol. 2008, 26: 365-373. 10.1007/s00345-008-0258-z.
Volk RJ, Jibaja-Weiss ML, Hawley ST, Kneuper S, Spann SJ, Miles BJ: Entertainment education for prostate cancer screening: a randomized trial among primary care patients with low health literacy. Patient Educ Couns. 2008, 73: 482-489. 10.1016/j.pec.2008.07.033.
Davison BJ, Kirk P, Degner LF, Hassard TH: Information and patient participation in screening for prostate cancer. Patient Educ Couns. 1999, 37: 255-263. 10.1016/S0738-3991(98)00123-2.
Gattellari M, Ward JE: Does evidence-based information about screening for prostate cancer enhance consumer decision-making? A randomised controlled trial. J Med Screen. 2003, 10: 27-39. 10.1258/096914103321610789.
Gattellari M, Ward JE: A community-based randomised controlled trial of three different educational resources for men about prostate cancer screening. Patient Educ Couns. 2005, 57: 168-182. 10.1016/j.pec.2004.05.011.
Myers RE, Daskalakis C, Cocroft J, Kunkel EJ, Delmoor E, Liberatore M: Preparing African-American men in community primary care practices to decide whether or not to have prostate cancer screening. J Natl Med Assoc. 2005, 97: 1143-1154.
Partin MR, Nelson D, Radosevich D, Nugent S, Flood AB, Dillon N: Randomized trial examining the effect of two prostate cancer screening educational interventions on patient knowledge, preferences, and behaviors. J Gen Intern Med. 2004, 19: 835-842. 10.1111/j.1525-1497.2004.30047.x.
Schapira MM, VanRuiswyk J: The effect of an illustrated pamphlet decision-aid on the use of prostate cancer screening tests. J Fam Pract. 2000, 49: 418-424.
Taylor KL, Davis JL, Turner RO, Johnson L, Schwartz MD, Kerner JF: Educating African American men about the prostate cancer screening dilemma: a randomized intervention. Cancer Epidemiol Biomarkers Prev. 2006, 15: 2179-2188. 10.1158/1055-9965.EPI-05-0417.
Volk RJ, Spann SJ, Cass AR, Hawley ST: Patient education for informed decision making about prostate cancer screening: a randomized controlled trial with 1-year follow-up. Ann Fam Med. 2003, 1: 22-28. 10.1370/afm.7.
Watson E, Hewitson P, Brett J, Bukach C, Evans R, Edwards A: Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested. Patient Educ Couns. 2006, 63: 367-379. 10.1016/j.pec.2006.05.005.
Wilt TJ, Paul J, Murdoch M, Nelson D, Nugent S, Rubins HB: Educating men about prostate cancer screening. A randomized trial of a mailed pamphlet. Eff Clin Pract. 2001, 4: 112-120.
Wolf AM, Nasser JF, Wolf AM, Schorling JB: The impact of informed consent on patient interest in prostate-specific antigen screening. Arch Intern Med. 1996, 156: 1333-1336. 10.1001/archinte.156.12.1333.
Berglund G, Nilsson S, Nordin K: Intention to test for prostate cancer. Eur J Cancer. 2005, 41: 990-997. 10.1016/j.ejca.2005.01.011.
Ellison GL, Weinrich SP, Lou M, Xu H, Powell IJ, Baquet CR: A randomized trial comparing web-based decision aids on prostate cancer knowledge for African-American men. J Natl Med Assoc. 2008, 100: 1139-1145.
Flood AB, Wennberg JE, Nease RF, Fowler FJ, Ding J, Hynes LM: The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team. J Gen Intern Med. 1996, 11: 342-349. 10.1007/BF02600045.
Frosch DL, Kaplan RM, Felitti V: The evaluation of two methods to facilitate shared decision making for men considering the prostate-specific antigen test. J Gen Intern Med. 2001, 16: 391-398. 10.1046/j.1525-1497.2001.016006391.x.
Ruthman JL, Ferrans CE: Efficacy of a video for teaching patients about prostate cancer screening and treatment. Am J Health Promot. 2004, 18: 292-295.
Taylor KL, Turner RO, Davis JL, Johnson L, Schwartz MD, Kerner J: Improving knowledge of the prostate cancer screening dilemma among African American men: an academic-community partnership in Washington, DC. Public Health Rep. 2001, 116: 590-598.
AMC Cancer Research Center: Beyond the Brochure: Alternative Approaches to Effective Health Communication. 1994, Atlanta, GA: CDC, [http://www.cdc.gov/cancer/nbccedp/pdf/amcbeyon.pdf]
Georgetown University Medical Center, The Most Worshipful Prince Hall Grand Lodge of the District of Columbia: The Right Decision is Yours: A Guide to Prostate Cancer. Funded by the U.S. Centers for Disease Control and Prevention, Cooperative Agreement #TS-290 and the National Cancer Institute, #KO7 CA72645. 2000, [http://lombardi.georgetown.edu/pdf/community/prostate_screening_handbook.pdf]
U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC): Prostate Cancer Screening: A Decision Guide. 2006, [http://www.cdc.gov/cancer/Prostate/pdf/prosguide.pdf]
Taylor KL, Schwartz M, Davis K, Zincke N, Williams R, Dawson D: Prostate cancer screening: fostering informed decisions. 2007, Presented at the Society of Behavioral Medicine annual meeting, Washington, DC
National Cancer Institute, U.S. National Institutes of Health. Prostate-Specific Antigen (PSA) Test: Questions and Answers. 2009, [http://www.cancer.gov/cancertopics/factsheet/Detection/PSA]
Weiss BD, Mays MZ, Martz W, Castro KM, DeWalt DA, Pignone MP: Quick assessment of literacy in primary care: the newest vital sign. Ann Fam Med. 2005, 3: 514-522. 10.1370/afm.405.
Friedman DB, Hoffman-Goetz L: A systematic review of readability and comprehension instruments used for print and web-based cancer information. Health Educ Behav. 2006, 33: 352-373. 10.1177/1090198105277329.
Elwyn G, O'Connor A, Stacey D, Volk R, Edwards A, Coulter A: Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ. 2006, 333: 417-10.1136/bmj.38926.629329.AE.
O'Connor AM: Ottawa Decision Support Framework to Address Decisional Conflict. 2006, [http://decisionaid.ohri.ca/docs/develop/ODSF.pdf]
Redelmeier DA, Rozin P, Kahneman D: Understanding patients' decisions. Cognitive and emotional perspectives. JAMA. 1993, 270: 72-76. 10.1001/jama.270.1.72.
Williams RM, Dorfman CS, Kassan EC, Red S, Dawson DL, Tuong W: Prostate Cancer Screening: Making the Best Choice. Public Health Education and Health Promotion. Award winning health education and promotion materials presentation. 2009, American Public Health Association annual meeting
Horrigan JB, Pew Internet American Life Project: Trends in Internet Adoption and Use: Comparing Minority Groups. 2004, [http://www.pewinternet.org/Presentations/2004/Trends-in-Internet-Adoption-and-Use.aspx]
Horrigan JB, Pew Internet American Life Project: Home Broadband Adoption. 2008, [http://pewresearch.org/pubs/888/home-broadband-adoption-2008]
Lillie SE, Brewer NT, O'Neill SC, Morrill EF, Dees EC, Carey LA: Retention and use of breast cancer recurrence risk information from genomic tests: the role of health literacy. Cancer Epidemiol Biomarkers Prev. 2007, 16: 249-255. 10.1158/1055-9965.EPI-06-0525.
Miller DP, Brownlee CD, McCoy TP, Pignone MP: The effect of health literacy on knowledge and receipt of colorectal cancer screening: a survey study. BMC Fam Pract. 2007, 8: 16-10.1186/1471-2296-8-16.
Health and Human Services Dept: Research-Based Web Design & Usability Guidelines. 2006, [http://www.usability.gov/refine/learnusa.html]
Stoddard JL: The importance of usability testing in the development of an internet-based smoking cessation treatment resource. Nicotine and Tobacco Research. 2006, 8: S87-S93. 10.1080/14622200601048189.
Fowler FJ, Bin L, Collins MM, Roberts RG, Oesterling JE, Wasson JH: Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists. Am J Med. 1998, 104: 526-532. 10.1016/S0002-9343(98)00124-7.
Sirovich BE, Schwartz LM, Woloshin S: Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?. JAMA. 2003, 289: 1414-1420. 10.1001/jama.289.11.1414.
Voss JD, Schectman JM: Prostate cancer screening practices and beliefs. J Gen Intern Med. 2001, 16: 831-837. 10.1046/j.1525-1497.2001.10133.x.
Yarnall KS, Pollak KI, Ostbye T, Krause KM, Michener JL: Primary care: is there enough time for prevention?. Am J Public Health. 2003, 93: 635-641. 10.2105/AJPH.93.4.635.
Dunn AS, Shridharani KV, Lou W, Bernstein J, Horowitz CR: Physician-patient discussions of controversial cancer screening tests. Am J Prev Med. 2001, 20: 130-134. 10.1016/S0749-3797(00)00288-9.
Carlsen B, Aakvik A: Patient involvement in clinical decision making: the effect of GP attitude on patient satisfaction. Health Expect. 2006, 9: 148-157. 10.1111/j.1369-7625.2006.00385.x.
Frosch DL, Kaplan RM: Shared decision making in clinical medicine: past research and future directions. Am J Prev Med. 1999, 17: 285-294. 10.1016/S0749-3797(99)00097-5.
Williams RM, Zincke NL, Turner RO, Davis JL, Davis KM, Schwartz MD: Prostate cancer screening and shared decision-making preferences among African-American members of the Prince Hall Masons. Psychooncology. 2008, 17: 1006-1013. 10.1002/pon.1318.
Woolf SH, Krist AH, Johnson RE, Stenborg PS: Unwanted control: how patients in the primary care setting decide about screening for prostate cancer. Patient Educ Couns. 2005, 56: 116-124. 10.1016/j.pec.2003.12.002.
National Center for Health Statistics, U.S.Department of Health and Human Services: Health, United States, 2007 with Chartbook on Trends in the Health of Americans. DHHS publication. 2007, [http://www.cdc.gov/nchs/data/hus/hus07.pdf] -1232. Hyattsville, MD
Gann PH, Hennekens CH, Stampfer MJ: A prospective evaluation of plasma prostate- specific antigen for detection of prostatic cancer. JAMA. 1995, 273 (4): 289-94. 10.1001/jama.273.4.289.
Labrie F, Dupont A, Suburu R, Cusan L, Tremblay M, Gomez JL, Emond J: Serum prostate specific antigen as pre-screening test for prostate cancer. J Urol. 1992, 147 (3 Pt 2): 846-51.
Mettlin C, Murphy GP, Babaian RJ, Chesley A, Kane RA, Littrup PJ, Mostofi FK, Ray PS, Shanberg AM, Toi A: The results of a five-year early prostate cancer detection intervention. Investigators of the American Cancer Society National Prostate Cancer Detection Project. Cancer. 1996, 77 (1): 150-9. 10.1002/(SICI)1097-0142(19960101)77:1<150::AID-CNCR25>3.0.CO;2-3.